Arrhythmia Research Technology, Inc. Announces New President and Chief Executive Officer
09 avr. 2013 08h57 HE
|
Arrhythmia Research Technology Inc.
FITCHBURG, MA--(Marketwired - Apr 9, 2013) - Arrhythmia Research Technology Inc. ("Company") (NYSE MKT: HRT) announces today that it has appointed Salvatore Emma, Jr. to serve as its President and...
Arrhythmia Research Technology, Inc. Announces Third Quarter Results
21 nov. 2012 17h36 HE
|
Arrhythmia Research Technology Inc.
FITCHBURG, MA--(Marketwire - Nov 21, 2012) - Arrhythmia Research Technology, Inc. (the "Company") (NYSE MKT: HRT) and its subsidiaries reported total revenue of $4,840,000 and net loss of...
Arrhythmia Research Technologies, Inc. Appoints Michael Gunter as Interim CEO
30 oct. 2012 14h40 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Oct 30, 2012) - Arrhythmia Research Technology, Inc. ("ART" or the "Company") (NYSE MKT: HRT) today announced the appointment of Michael S. Gunter, a director, as...
Arrhythmia Research Technology, Inc. Announces Second Quarter Results
14 août 2012 11h14 HE
|
Arrhythmia Research Technology Inc.
FITCHBURG, MA--(Marketwire - Aug 14, 2012) - Arrhythmia Research Technology, Inc. (the "Company") (NYSE MKT: HRT) and its subsidiaries reported total revenue of $4,977,000 and net loss of...
Arrhythmia Research Technology, Inc. Announces First Quarter 2012 Results
17 mai 2012 17h09 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - May 17, 2012) - Arrhythmia Research Technology, Inc. (the "Company") (NYSE MKT: HRT) (NYSE Amex: HRT) and its subsidiaries reported total revenue of $6,305,000 and net...
Arrhythmia Research Technology, Inc. Regains Compliance With NYSE Amex Exchange Continuing Listing Standards
30 avr. 2012 09h46 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Apr 30, 2012) - Arrhythmia Research Technology, Inc. (NYSE Amex: HRT) (the "Company"), a supplier of medical components, software and services, announced that the NYSE...
Arrhythmia Research Technology, Inc. Announces Fourth Quarter and 2011 Year End Results
25 avr. 2012 17h45 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Apr 25, 2012) - Arrhythmia Research Technology, Inc. (NYSE Amex: HRT)
2011 Highlights
Increase of 40% in sensor sales
...
Arrhythmia Research Technology, Inc. Receives NYSE Amex Exchange Compliance Notice
23 avr. 2012 16h24 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Apr 23, 2012) - Arrhythmia Research Technology, Inc. (NYSE Amex: HRT) (the "Company") announced that, on April 17, 2012, it received notice from the NYSE Amex LLC (the...
Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Fourth Quarter and 2011 Year End Results
17 avr. 2012 11h08 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Apr 17, 2012) - Arrhythmia Research Technology, Inc. (NYSE Amex: HRT) (the "Company") reported today that it was unable to file its annual report on Form 10-K for the...
Arrhythmia Research Technology, Inc. Declares Cash Dividend
25 janv. 2012 16h30 HE
|
Arrhythmia Research Technology, Inc.
FITCHBURG, MA--(Marketwire - Jan 25, 2012) - Arrhythmia Research Technology, Inc. (the "Company") (NYSE Amex: HRT) announced that its Board of Directors declared a quarterly cash dividend of $0.03...